Metformin ameliorates peripheral insulin resistance by inhibiting the activity of SHIP2

被引：0
|
作者：
Lehtonen, S. [1 ]
Polianskyte-Prause, Z. [1 ]
Tolvanen, T. A. [1 ]
Lindfors, S. [1 ]
Latvala, M. [1 ]
Wang, H. [1 ]
Dash, S. N. [1 ]
Berg, M. [2 ]
Dumont, V. [1 ]
Groop, P. -H. [3 ,4 ]
Wahala, K. [2 ]
Tienari, J. [5 ,6 ]
机构：
[1] Univ Helsinki, Pathol, Helsinki, Finland
[2] Univ Helsinki, Chem, Helsinki, Finland
[3] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[4] Helsinki Univ Hosp, Div Nephrol, Helsinki, Finland
[5] HUSLAB, Pathol, Helsinki, Finland
[6] Helsinki Univ Hosp, Helsinki, Finland
来源：
DIABETOLOGIA | 2016年 / 59卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
505
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [1] Overexpression of SHIP2 causes insulin resistance in peripheral tissues and brain of mice
    Soeda, Yoshiyuki
    Tsuneki, Hiroshi
    Kagawa, Syota
    Wada, Tsutomu
    Sasaoka, Toshiyasu
    DIABETES, 2008, 57 : A381 - A381
  • [2] IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity
    Wu, Chongchao
    Cui, Xiaofang
    Huang, Liyu
    Shang, Xueying
    Wu, Binghao
    Wang, Na
    He, Kunyan
    Han, Zeguang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [3] Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity
    Polianskyte-Prause, Zydrune
    Tolvanen, Tuomas A.
    Lindfors, Sonja
    Dumont, Vincent
    Van, Mervi
    Wang, Hong
    Dash, Surjya N.
    Berg, Mika
    Naams, Jette-Britt
    Hautala, Laura C.
    Nisen, Harry
    Mirtti, Tuomas
    Groop, Per-Henrik
    Wahala, Kristiina
    Tienari, Jukka
    Lehtonen, Sanna
    FASEB JOURNAL, 2019, 33 (02): : 2858 - 2869
  • [4] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes
    Sasaoka, T
    Fukui, K
    Wada, T
    Murakami, S
    Kawahara, J
    Ishihara, H
    Funaki, M
    Asano, T
    Kobayashi, M
    DIABETOLOGIA, 2005, 48 (02) : 336 - 344
  • [5] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by the chronic insulin treatment in 3T3-L1 adipocytes
    Fukui, K
    Sasaoka, T
    Wada, T
    Murakami, S
    Ishihara, H
    Hiratani, K
    Kawahara, J
    Kobayashi, M
    DIABETES, 2003, 52 : A286 - A286
  • [6] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes
    T. Sasaoka
    K. Fukui
    T. Wada
    S. Murakami
    J. Kawahara
    H. Ishihara
    M. Funaki
    T. Asano
    M. Kobayashi
    Diabetologia, 2005, 48 : 336 - 344
  • [7] PolyMet-HA nanocomplexs regulates glucose uptake by inhibiting SHIP2 activity
    Yuan, Xinlu
    Ding, Ling
    Diao, Jianjun
    Wen, Song
    Xu, Chenglin
    Zhou, Ligang
    Du, Anqing
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2021, 35 (07) : 849 - 856
  • [8] Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade
    Bertelli, DF
    Ueno, M
    Amaral, MEC
    Toyama, MH
    Carneiro, EM
    Marangoni, S
    Carvalho, CRO
    Saad, MJA
    Velloso, LA
    Boschero, AC
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (04): : E679 - E687
  • [9] The lipid phosphatase SHIP2 controls insulin sensitivity
    Clément, S
    Krause, U
    Desmedt, F
    Tanti, JF
    Behrends, J
    Pesesse, X
    Sasaki, T
    Penninger, J
    Doherty, M
    Malaisse, W
    Dumont, JE
    Le Marchand-Brustel, Y
    Erneux, C
    Hue, L
    Schurmans, S
    NATURE, 2001, 409 (6816) : 92 - 97
  • [10] The lipid phosphatase SHIP2 controls insulin sensitivity
    Serge Clément
    Ulrike Krause
    Florence Desmedt
    Jean-François Tanti
    Jens Behrends
    Xavier Pesesse
    Takehiko Sasaki
    Joseph Penninger
    Margaret Doherty
    Willy Malaisse
    Jacques E. Dumont
    Yannick Le Marchand-Brustel
    Christophe Erneux
    Louis Hue
    Stéphane Schurmans
    Nature, 2001, 409 : 92 - 97
12345